共 71 条
[1]
Castelli W.P., Anderson K., Wilson P.W., Levy D., Lipids and risk of coronary heart disease: The Framingham Study, Ann Epidemiol, 2, pp. 23-28, (1992)
[2]
Gordon D.J., Rifkind B.M., High-density lipoprotein: The clinical implications of recent studies, N Engl J Med, 321, pp. 1311-1316, (1989)
[3]
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S), Lancet, 344, pp. 1383-1389, (1994)
[4]
Shepherd J., Cobbe S.M., Ford I., Et al., Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, N Engl J Med, 333, pp. 1350-1351, (1995)
[5]
Sacks F.M., Pfeffer M.A., Moye L.A., Et al., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, N Engl J Med, 335, pp. 1001-1009, (1996)
[6]
Downs J.R., Clearfield M., Weis S., Et al., Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study, JAMA, 279, pp. 1615-1622, (1998)
[7]
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial, Lancet, 360, pp. 7-22, (2002)
[8]
Genest Jr J.J., Bard J.M., Fruchart J.C., Et al., Familial hypoalphalipoproteinemia in premature coronary artery disease, Arterioscler Thromb, 13, pp. 1728-1737, (1993)
[9]
Badimon J.J., Badimon L., Fuster V., Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit, J Clin Invest, 85, pp. 1234-1241, (1990)
[10]
Rubin E.M., Krauss R.M., Spangler E.A., Et al., Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature, 353, pp. 265-267, (1991)